Eli Lilly
Joined in Longevity biotech. Invested in NewLimit's 2025 extension round through Eli Lilly and Company.
Public companyUSfounded 18761 field
| Technology | ||
|---|---|---|
| Longevity biotechInvested in NewLimit's 2025 extension round through Eli Lilly and Company. | Invested in NewLimit's 2025 extension round through Eli Lilly and Company. | blog.newlimit.com |